Company Overview - Cannabix Technologies Inc. is a Canada-based developer of biosensor technologies focused on the rapid, non-invasive detection of cannabis impairment [4] - The company's flagship product is a handheld breathalyzer device designed to identify recent use of tetrahydrocannabinol (THC) within minutes of exhalation, providing a tool for law enforcement and public safety organizations [4] Financial Performance - As of December 15, Cannabix Technologies had a market capitalization of $51.33 million, with a PE ratio of -21.20 and a beta of 0.65 [3] - The stock opened at $0.42, with a twelve-month low of $0.20 and a high of $0.50 [3] - The firm's 50-day moving average price is $0.39 and its 200-day moving average price is $0.41 [3] Short Interest Activity - There was a significant increase in short interest for Cannabix Technologies during December, with total short interest reaching 52,257 shares, a growth of 105.8% from 25,390 shares on November 30 [2] - Currently, 0.0% of the shares are short sold, and the short-interest ratio is 0.2 days based on an average daily trading volume of 221,578 shares [2][2]